oxybutynin has been researched along with ethinyl estradiol in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 30 (85.71) | 24.3611 |
| 2020's | 3 (8.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Graziottin, A | 1 |
| Bodner, K; Bodner-Adler, B; Grünberger, W | 1 |
| Aweeka, F; Cohn, SE; Kamemoto, L; Klingman, KL; Park, JG; Patterson, K; Vogler, MA; Watts, H | 1 |
| Bodmeier, R; Fussnegger, B; Schulz, M | 1 |
| Bergmans, P; Chernev, T; Crosignani, PG; Jakimiuk, AJ; Lee, EJ; Marelli, S; Prilepskaya, V; Von Poncet, M | 1 |
| Barbier, M; Dréan, Y; Lalou, Y; Lanta, S; Mention, JE | 1 |
| Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS | 1 |
| Mishell, DR; Roumen, FJ | 1 |
| Archer, DF; Foegh, M; Rubin, A; Stanczyk, FZ | 2 |
| Heger-Mahn, D; Junge, W; Merz, M; Trummer, D | 1 |
| Grunert, J; Merz, M | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
| Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
| Bassol, S; Mellinger, U; Merz, M; Weisberg, E; Wiegratz, I | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
| Bangerter, K; Merz, M; Reinecke, I; Westhoff, CL | 1 |
| Goldammer, M; Ludwig, M; Rohde, B; Winkler, J; Zurth, C | 1 |
| Höchel, J; Ludwig, M; Schuett, B; Zurth, C | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
| Hofmann, B; Merz, M; Reinecke, I; Schuett, B; Zurth, C | 1 |
| Gruber, D; Lanius, V; Merz, M; Serrani, M; Skřivánek, A | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Westhoff, CL | 2 |
| Duijkers, I; Klipping, C; Rautenberg, T; Rohde, B; Waellnitz, K; Zurth, C | 1 |
| Casjens, M; Ludwig, M; Schuett, B; Waellnitz, K; Zurth, C | 1 |
| Ackerman, KE; Baskaran, C; Bouxsein, ML; Campoverde Reyes, KJ; Eddy, KT; Klibanski, A; Lee, H; Misra, M; Singhal, V; Slattery, M; Toth, A | 1 |
| Ariyawansa, J; Fonseca, S; Massarella, J; Natarajan, J; Parasrampuria, DA; Rasschaert, F; Swinnen, A; Vaughan, S | 1 |
| Fonseca, S; Nangosyah, J; Sanga, M; Scholz, V; Vaughan, S | 1 |
| Afzal, A; Bibi, S; Hussain, T; Javaid, Z; Kainat, -; Tabassum, M; Zaman, K | 1 |
2 review(s) available for oxybutynin and ethinyl estradiol
| Article | Year |
|---|---|
A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch.
Topics: Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Humans; Nandrolone; Randomized Controlled Trials as Topic; Transdermal Patch | 2006 |
The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
Topics: Administration, Intravaginal; Contraception Behavior; Contraceptive Agents; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Acceptance of Health Care; Transdermal Patch; Treatment Outcome | 2012 |
23 trial(s) available for oxybutynin and ethinyl estradiol
| Article | Year |
|---|---|
Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Middle Aged; Norgestrel; Oximes; Pyrimidinones; Ritonavir; Transdermal Patch; United States | 2010 |
High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Europe; Female; Humans; Middle Aged; Norgestrel; Patient Preference; Patient Satisfaction; Pregnancy; Pregnancy Rate; Quality of Life; Self Report; Transdermal Patch; Young Adult | 2011 |
Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise.
Topics: Adhesives; Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Equipment Failure; Ethinyl Estradiol; Exercise; Female; Hot Temperature; Humans; Humidity; Immersion; Levonorgestrel; Middle Aged; Transdermal Patch; Water | 2013 |
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch.
Topics: Abdomen; Adult; Buttocks; Cohort Studies; Contraceptive Agents, Female; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Feasibility Studies; Female; Half-Life; Headache; Humans; Incidence; Levonorgestrel; Nausea; Pruritus; Skin Absorption; Thorax; Transdermal Patch; United States; Young Adult | 2013 |
Investigation of the hemostatic effect of a transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene compared with a monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel: an open-label, randomize
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Norpregnenes; Patient Compliance; Prothrombin Time; Transdermal Patch; Treatment Outcome; Young Adult | 2013 |
Effects of an ethinyl estradiol/gestodene transdermal contraceptive patch on the endometrium: a single-center, uncontrolled study.
Topics: Administration, Cutaneous; Adult; Contraceptive Agents, Female; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progestins; Transdermal Patch; Treatment Outcome; Vagina; Young Adult | 2014 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Australia; Chile; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Europe; Female; Humans; Medication Adherence; Menstruation; Mexico; Norpregnenes; Pregnancy; Pregnancy, Unplanned; Pregnancy, Unwanted; Time Factors; Transdermal Patch; Young Adult | 2014 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicular Phase; Follow-Up Studies; Humans; Lost to Follow-Up; Norpregnenes; Obesity; Oogenesis; Ovarian Follicle; Overweight; Ovulation Inhibition; Progesterone; Sex Hormone-Binding Globulin; Transdermal Patch; Ultrasonography; Young Adult | 2014 |
Pharmacokinetic drug-drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate.
Topics: Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Ethinyl Estradiol; Female; Humans; Middle Aged; Norpregnenes; Substrate Specificity; Transdermal Patch; Young Adult | 2015 |
Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study.
Topics: Adolescent; Adult; Biological Availability; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Middle Aged; Norpregnenes; Sex Hormone-Binding Globulin; Transdermal Patch | 2014 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive.
Topics: Adult; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Norpregnenes; Transdermal Patch | 2014 |
A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study.
Topics: Adolescent; Adult; Amenorrhea; Austria; Contraceptive Agents, Female; Czech Republic; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Mastodynia; Menorrhagia; Menstrual Cycle; Metrorrhagia; Netherlands; Norgestrel; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; Young Adult | 2015 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.
Topics: Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Patient Compliance; Reproducibility of Results; Self Report; Transdermal Patch; Young Adult | 2015 |
New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.
Topics: Adhesiveness; Adolescent; Adult; Contraceptives, Oral, Combined; Dermatitis, Contact; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Research Personnel; Transdermal Patch; Young Adult | 2015 |
A two-centre, open-label, randomised study of ovulation inhibition with three transdermal contraceptive patches, each containing different amounts of ethinyl estradiol and gestodene in healthy, young women.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovulation Inhibition; Transdermal Patch; Young Adult | 2016 |
Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study.
Topics: Adhesiveness; Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Exercise; Female; Germany; Hot Temperature; Humans; Humidity; Medication Adherence; Metabolic Clearance Rate; Middle Aged; Norpregnenes; Transdermal Patch; Young Adult | 2015 |
Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adult; Amenorrhea; Athletes; Bone Density; Desogestrel; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Transdermal Patch; Young Adult | 2019 |
Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: A double-blind, randomized, bioequivalence and adhesion study in healthy women.
Topics: Adhesives; Adult; Contraceptive Agents, Hormonal; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Therapeutic Equivalency; Transdermal Patch | 2020 |
Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life.
Topics: Adhesives; Contraceptive Agents; Cross-Over Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norgestrel; Therapeutic Equivalency; Transdermal Patch | 2022 |
10 other study(ies) available for oxybutynin and ethinyl estradiol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Middle Aged; Norgestrel; Patient Compliance; Patient Satisfaction; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unplanned; Pregnancy, Unwanted; Transdermal Patch; Treatment Outcome; Young Adult | 2011 |
Influence of adsorbents in transdermal matrix patches on the release and the physical state of ethinyl estradiol and levonorgestrel.
Topics: Administration, Cutaneous; Adsorption; Contraceptive Agents, Female; Crystallization; Delayed-Action Preparations; Drug Compounding; Estrogens; Ethinyl Estradiol; Humans; Levonorgestrel; Molecular Weight; Particle Size; Povidone; Solubility; Transdermal Patch; Water | 2011 |
[Early home abortion and immediate contraception with Evra® patch].
Topics: Abortion, Induced; Adolescent; Adult; Contraception, Postcoital; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Mifepristone; Norgestrel; Pregnancy; Transdermal Patch; Young Adult | 2011 |
Adolescents' experiences using the contraceptive patch versus pills.
Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult | 2011 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |
gestodene + ethinvlestradiol (APLEEK⁰). No place for a patch containing a third-generation progestin.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Drug Combinations; Ethinyl Estradiol; Humans; Norpregnenes; Transdermal Patch | 2016 |
Formulation and characterization of nanoparticle-based ethinyl estradiol transdermal drug delivery system for contraception and menopausal disorders.
Topics: Administration, Cutaneous; Contraception; Drug Delivery Systems; Ethinyl Estradiol; Humans; Menopause; Nanoparticle Drug Delivery System; Nanoparticles; Skin Absorption; Transdermal Patch | 2023 |